Back to dashboard
MedicaidCoverageLow impact

Newsletter Vol. 9, No. 78

New Jersey Medicaid·NJ · Pharmacy·Pharmacy
Effective date
Feb 21, 1999
We identified it
Jun 20, 2026
Days to comply

Summary

This policy adds four new pharmaceutical manufacturers to the New Jersey PAAD (Pharmaceutical Assistance to the Aged and Disabled) Drug Rebate Program. Billing teams must recognize these newly added manufacturer labeler codes (58468, 59291, 63395, 64065) for claim processing and ensure proper coverage determination under PAAD, noting that PAAD coverage may differ from Medicaid coverage for the same drugs.

Action Required

Action needed
By January 2000: Pharmacy billing staff should update internal reference materials and claims processing systems to recognize the four new manufacturer labeler codes (Genzyme Corporation 58468, Iyata Pharmaceutical Inc. 59291, Daiichi Pharmaceutical Corporation 63395, Medical Resources Inc. 64065) for PAAD eligibility verification. Ensure claims processing distinguishes between PAAD and Medicaid coverage rules, as manufacturer participation differs between programs. Note: This policy is from December 1999 and may be superseded by more recent guidance; verify current PAAD manufacturer lists with the N.J. Division of Medical Assistance and Health Services before implementation.